QinYLiangXWuH, et al. Development and validation of a modified Khorana score for predicting venous thromboembolism in newly diagnosed stage IV lung cancer. Angiology. 2025;76(3):264-270.
2.
KhoranaAAKudererNMCulakovaELymanGHFrancisCW.Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902-4907.
3.
van EsNVentrescaMDi NisioM, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis. J Thromb Haemost. 2020;18(8):1940-1951.
4.
BlomJWOsantoSRosendaalFR.The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost. 2004;2(10):1760-1765.
5.
CampelloEIlichASimioniPKeyNS.The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br J Cancer. 2019; 21(5):359-371.
6.
AyCDunklerDMarosiC, et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116(24):5377-5382.
7.
SallaEDimakakosEPTsagkouliS, et al. Venous thromboembolism in patients diagnosed with lung cancer. Angiology. 2016;67(8):709-724.
